In a large, multi-year clinical trial, children of mothers who took choline supplements during pregnancy had fewer social withdrawal problems and increased cognitive test performance through age 4 ...

Five leading scientists recognized for groundbreaking research in schizophrenia, mood disorders, child and adolescent mental health, and cognitive neuroscience NEW YORK, October 21, 2026 — The Brain & ...

Researchers found that patients in the early stages of psychosis have abnormally low levels of an enzyme called ACE, which helps regulate blood pressure. The gene that encodes ACE is a validated ...

From The Quarterly, Summer 2011 Psychotic depression, which is major depressive disorder combined with psychotic delusions or hallucinations, often goes undiagnosed. The kinds of delusions that tend ...

Dr. Volkow, in a recent paper in the American Journal of Psychiatry, you and a co-author noted that the increased prevalence of more powerful opioids and drug mixtures in the illicit market has led to ...

Over $12.5 million in two-year awards—selected from 993 applications—will support early-career research acrossdepression, schizophrenia, anxiety, PTSD, addiction, autism, and more ...

One of the most promising new therapy ideas for brain and behavior disorders may at first seem improbable” using opioid-based medicines to reduce the symptoms of depression. Learn about how opioids ...

Discoveries span autism, depression, schizophrenia, PTSD, addiction, and early intervention—advancing next-generation treatments and prevention strategies NEW YORK (January 7, 2026) — The Brain & ...

Using Danish national health records, investigators found that cannabis use disorder (CUD) is contributing to a “steadily increasing proportion” of schizophrenia cases over the last 5 decades—a figure ...

KarXT, a new medicine for treating schizophrenia—one that appears to help reduce both positive and negative symptoms of the illness—has passed a first hurdle in phase 3 clinical testing. If ultimately ...

A new study indicated that Cobenfy, a new drug for schizophrenia approved by the FDA in September 2024, may help reduce cognitive impairments in some patients, in addition to its previously documented ...

Traumatized combat veterans with severe PTSD had larger reductions in symptoms with active acupuncture vs. a “sham” version of the treatment. Active acupuncture was described by researchers as ...